To find clinical trials near you:
Purpose: To identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Purpose: To determine whether intensive blood pressure lowering will reduce the incidence of all-cause dementia, reduce the decline of global cognitive function in key specific domains, and show changes in brain structure.
Purpose: To identify the genes that are responsible for causing Alzheimer's disease by collecting genetic material from families with multiple members diagnosed with AD.
Purpose: To examine how brain imaging technology and other tests can measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease in order to detect Alzheimer's early and measure the effectiveness of treatments in future clinical trials.
Purpose: To evaluate the safety of deep brain stimulation of the fornix (DBS-f) in people with mild Alzheimer's disease.